Sedative, hypnotic or anxiolytic use, unspecified with unspecified sedative, hypnotic or anxiolytic-induced disorder
ICD-10 F13.99 is a billable code used to indicate a diagnosis of sedative, hypnotic or anxiolytic use, unspecified with unspecified sedative, hypnotic or anxiolytic-induced disorder.
F13.99 refers to a condition characterized by the use of sedatives, hypnotics, or anxiolytics that leads to an unspecified disorder. This code encompasses a range of issues related to substance use disorders, including addiction, withdrawal symptoms, and intoxication. Patients may present with various symptoms such as anxiety, insomnia, or agitation, which can complicate their clinical picture. The unspecified nature of the code indicates that the specific substance involved is not documented, making it essential for healthcare providers to conduct thorough assessments to identify the substance and its effects. Treatment may involve detoxification, counseling, and rehabilitation programs tailored to the individual's needs. Understanding the nuances of this code is crucial for accurate documentation and appropriate treatment planning.
Detailed patient history, including substance use patterns and treatment responses.
Patients presenting with withdrawal symptoms or seeking treatment for substance use.
Consideration of co-occurring mental health disorders and comprehensive treatment plans.
Thorough psychiatric evaluation and documentation of mental health history.
Patients with anxiety or sleep disorders exacerbated by substance use.
Assessment of the impact of substance use on mental health and treatment outcomes.
Used when assessing a patient for substance use disorder.
Document the assessment findings and treatment plan.
Ensure alignment with addiction medicine protocols.
Document the patient's substance use history, symptoms, treatment provided, and any co-occurring mental health disorders to support the use of this code.
